Legend Biotech Corporation - American Depositary Shares (LEGN) earnings
LEGN earnings moved a median of -0.26% by the close. Quarterly and annual LEGN reports and results, each read against the price at its own news timestamp. Back to the LEGN overview →
20 measured LEGN earnings events.
Where these LEGN earnings landedvs 20 measured LEGN earnings reactions
| Middle 50% of LEGN earnings reactions | -4.34% to +0.71% |
|---|---|
| Median reaction (to close) | -0.26% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 LEGN earnings events with a measured close landed between -4.34% and +0.71%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Legend Biotech Reports Third Quarter 2026 Results and Recent Highlights | Press release | +1.74% | -4.31% | |
| Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results | Press release | -1.52% | +5.74% | |
| Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights | Press release | -2.73% | +0.88% | |
| Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results | Press release | -1.46% | -0.52% | |
| Legend Biotech Reports First Quarter 2026 Results and Recent Highlights | Press release | -0.49% | +14.74% | |
| Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results | Press release | -0.98% | +0.81% | |
| Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights | Press release | -2.10% | -4.43% | |
| Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results | Press release | -0.69% | -0.86% | |
| Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights | Press release | -4.02% | -2.84% | |
| Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results | Press release | -1.27% | -5.03% | |
| Legend Biotech Reports First Quarter 2025 Results and Recent Highlights | Press release | -4.29% | +0.35% | |
| Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results | Press release | -0.32% | +0.00% | |
| Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights | Press release | +1.83% | +0.68% | |
| Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results | Press release | -0.50% | +0.66% | |
| Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights | Press release | -5.84% | -5.09% | |
| Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results | Press release | -0.15% | +1.63% | |
| Legend Biotech Reports First Quarter 2024 Results and Recent Highlights | Press release | -7.87% | -7.15% | |
| Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results | Press release | +0.00% | -0.88% | |
| GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30% | Press release | +0.93% | +0.56% | |
| Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights | Press release | -1.30% | -5.53% |
Keep exploring
More LEGN: analyst actions → · SEC filings → · LEGN overview →